ECM
ODT

ExodusPoint Capital Management’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

ExodusPoint Capital Management’s Portfolio ODT Stock Details ODT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-12,108
Closed -$16K – 2883
2021
Q4 		$16K Buy
+12,108
New +$28.6K ﹤0.01% 2092
2020
Q3 		– Sell
-7,600
Closed -$322K – 2396
2020
Q2 		$322K Buy
+7,600
New +$246K 0.01% 1286

Other funds holding ODT

BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

ExodusPoint Capital Management's ODT Position: Q1 2022 in Review

ExodusPoint Capital Management sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q1 2022, closing a stake of 12,108 shares — an estimated $16K sold.

ExodusPoint Capital Management first reported a position in ODT in Q2 2020 and held it in 2 quarters. The position peaked at $322K in Q2 2020. 8 funds tracked by Wall St. Rank hold ODT as of Q1 2022.

  • ExodusPoint Capital Management reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • ExodusPoint Capital Management sold 12,108 Odonate Therapeutics, Inc. Common Stock shares in Q1 2022, an estimated $16K.
  • ExodusPoint Capital Management first reported a position in Odonate Therapeutics, Inc. Common Stock in Q2 2020 and held it in 2 quarters.
  • ExodusPoint Capital Management's Odonate Therapeutics, Inc. Common Stock position peaked at $322K in Q2 2020.
  • 8 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q1 2022.

Based on ExodusPoint Capital Management's 13F filing for Q1 2022, filed 13 May 2022.